Article PDF
References
Lippa EA, Carlson LE, Ehinger B, et al. Dose response and duration of action of dorzolamide, a topical carbonic anhydrase inhibitor. Arch Ophthalmol 1992;110:495–9.
Gunning FP, Greve EL, Bron AM, et al. Two topical carbonic anhydrase inhibitors sezolamide and dorzolamide in gelrite vehicle: a multiple-dose efficacy study. Graefes Arch Clin Exp Ophthalmol 1993;231:384–8.
Strahlman E, Tipping R, Vogel R . A double-masked, randomised 1-year study comparing dorzolamide (Tru-sopt), timolol, and betaxolol. Arch Ophthalmol 1995;113:1009–16.
Wilkerson M, Marshall C, Lippa EA, et al. Four week safety and efficacy study of dorzolamide, a novel, active topical carbonic anhydrase inhibitor. Arch Ophthalmol 1993;111:1343–50.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Zambarakji, H., Spencer, A. & Vernon, S. An unusual side effect of dorzolamide. Eye 11, 418–419 (1997). https://doi.org/10.1038/eye.1997.88
Issue Date:
DOI: https://doi.org/10.1038/eye.1997.88